Potts Memorial Foundation
Historical funder research: IRS Form 990-PF filings from US private foundations, showing who funded what in past years. This is not a list of currently open grant calls, and we do not track open RFPs from private foundations. From public IRS Form 990-PF filings (latest on file for this funder: tax year 2025). Coverage: tax years 2019–2025. Freshness: the IRS releases these returns 1.5–2+ years after the tax year ends, so 2025 is still partial and a funder's newest grants may not appear yet. Last updated: November 14, 2026. Filings can contain errors, so confirm current priorities and deadlines with the funder before applying.
Year 2025 is still partial because many returns have not been filed or released yet. That is a freshness issue — coverage in our dataset is tax years 2019–2025.
Only 31.0% of this funder's organizational grants could be linked to an IRS cause code.
- Form & materials
- GRANT REQUESTS SHOULD BE WRITTEN AND CONTAIN PURPOSE OF GRANT
- Deadlines
- NONE
- Restrictions
- GRANTS GIVEN TO LUNG, T.B., BLOOD-OXYGEN RESEARCH AND/OR EQUIPMENT ONLY
| Recipient | Location | Purpose (as filed) | Amount | Tax yr |
|---|---|---|---|---|
| The Rockefeller University | New York, NY | RESEARCH PEBBLE: SUSTAINING AND EXPANDING A CRITICAL RESOURCE FOR CRISPR-BASED FUNCTIONAL GENOMICS IN MYCOBACTERIA | $50,000 | 2025 |
| Trustees of Tufts University | Boston, MA | RESEARCH UNDERSTANDING REGULATION OF CALCIUM-MEDIATED EFFECTS ON MYCOBACTERIUM TUBERCULOSIS GROWTH. | $50,000 | 2025 |
| Weill Cornell Medical College | New York, NY | RESEARCH GENIC NETWORKS THAT PREVENT KILLING OF MYCOBACTERIUM TUBERCULOSIS BY ATP SYNTHASE INHIBITORS | $37,000 | 2025 |
| Trustees of Columbia University | New York, NY | RESEARCH EARLY HOST BIOMARKERS OF CLINICAL OUTCOMES IN MDR-TB AND HIV CO-INFECTION USING OLINK PROTEOMICS | $36,000 | 2025 |
| Washington University School of Medicine | St Louis, MO | RESEARCH THE NONCANONICAL AND RAPID IFN-1 INDUCTION BY NEUTROPHILS IN RESPONSE TO MYCOBACTERIUM TUBERCULOSIS. | $25,000 | 2025 |
| Trudeau Institute | Saranac Lake, NY | SUPPORT THE NORTHEAST REGIONAL WORLD TB DAY CONFERENCE. | $25,000 | 2025 |
| Johns Hopkins University School of Medicine | Baltimore, MD | RESEARCHING THE ELIMINATION OF SENESCENT CELLS WITH SENOLYTIC HOST-DIRECTED THERAPY REDUCES TUBERCULOSIS PROGRESSION IN SUSCEPTIBLE MOUSE MODELS. | $25,000 | 2025 |
| Umass Chan Medical School | Worcester, MA | RESEARCH UNDERSTANDING THE ROLE OF HIGH-FREQUENCY GENETIC VARIATION IN TUBERCULOSIS TREATMENT FAILURE | $25,000 | 2025 |
| Weill Cornell Medical College | New York, NY | RESEARCH OF POST-TUBERCULOSIS LUNG DISEASE IN PEOPLE LIVING WITH HIV: MATRIX METALLOPROTEINASES AND THE AGE-RAGE AXIS | $20,000 | 2025 |
| Weill Cornell Medical College | New York, NY | POST DOC FELLOWSHIP FOR TB RESEARCH | $60,000 | 2024 |
| Weill Cornell Medical College | New York, NY | STIPEND FOR TB RESEARCH | $52,500 | 2024 |
| Worcester Polytechnic Institute | Worcester, MA | THE ROLE OF TRPG IN ARTEMISININ ACTIVITY | $30,000 | 2024 |
| Trustees of Tufts University | Boston, MA | EXPLORING THE ROLE OF CALCIUM HOMEOSTASIS IN MTB | $30,000 | 2024 |
| Trudeau Institute | Saranac Lake, NY | TARGET VALIDATION AND PHARMACOKINETIC EVALUATION OF RAPIDLY TUBERCULOCIDAL COMPOUNDS | $30,000 | 2024 |
| Johns Hopkins University School of Medicine | Baltimore, MD | RNA SENSOR LGP2 AND ITS ROLE DURING TB INFECTION | $25,000 | 2024 |
| Trustees of Columbia University | New York, NY | USE OF XPERT MTB/RIF ULTRA AND NOVEL HIGH DIMENSIONAL PROTEOMICS... | $20,702 | 2024 |
| Health Research Inc | Menands, NY | WORLD TB DAY SUPPORT | $15,520 | 2024 |
| Weill Cornell Medical College | New York, NY | INSIGHTS INTO THE TRANSMISSION BIOLOGY OF M. TUBERCULOSIS | $50,000 | 2023 |
| Rutgers NJ Medical School Public Health Research Institute | Newark, NJ | INVESTIGATION OF IMMUNE MECHANISMS REGULATING HETEROGENEITY | $47,560 | 2023 |
| Weill Cornell Medical College | New York, NY | STUDYING THE ROLE OF MACROPHAGES AND GLUCONEOGENESIS IN THE REGULATION OF MYCOBACTERIUM TUBERCULOSIS PERSISTENCE IN A MOUSE MODEL OF LATENCY | $46,250 | 2023 |
| Trudeau Institute | Saranac Lake, NY | IN VIVO VALIDATION OF A NOVEL MYCOBACTERIUM TUBERCULOSIS DRUG TARGET, ASPC | $25,000 | 2023 |
| Nyu Grossman Medicine | New York, NY | WORLD TUBERCULOSIS DAY SUPPORT | $25,000 | 2023 |
| Columbia Memorial Health Foundation | Hudson, NY | TO PURCHASE A HAMILTON-C1 PORTABLE VENTILATOR | $18,500 | 2023 |
| Weill Cornell Medical College | New York, NY | STUDYING THE ROLE OF MACROPHAGES AND GLUCONEOGENESIS IN THE REGULATION OF MYCOBACTERIUM TUBERCULOSIS PERSISTENCE IN A MOUSE MODEL OF LATENCY | $61,875 | 2022 |
| University of Georgia | Athens, GA | "EVALUATION OF THE ROLE OF MYELOID-DERIVED SUPPRESSOR CELLS IN THE IMMUNE RESPONSE TO MYCOBACTERIUM TUBERCULOSIS" | $50,000 | 2022 |
Grants to individuals are counted but not named.
The free funder search finds foundations that funded organizations like your client's, by cause and location. Free templates: multi-client grant calendar, grant tracker. GrantCorral is a workspace for grant consultants with several clients; founding members get 60 days free on Consultant, no card required, then 50% off the first year if they stay.